FDA Brief

Warning letters Drugs

FDA warning letter to

Elite Health Center

LowIssued Sep 9, 2025Posted Sep 16, 2025Center for Drug Evaluation and Research (CDER)

FDA warned Elite Health Center that its website falsely implied compounded semaglutide was FDA-approved, making the drugs misbranded.

What happened

FDA reviewed the website https://eliterapidfatloss.com in August 2025 and found it offered compounded drug products, including semaglutide. FDA said a website claim that compounded semaglutide was FDA-approved for obesity was false or misleading because compounded drugs are not FDA-approved. FDA called the products misbranded.

What FDA found

  1. The website claimed compounded semaglutide was FDA-approved for obesity, which falsely implies the compounded products are the same as an FDA-approved drug.

    FDCA § 502(a), 21 U.S.C. § 352(a); FDCA § 502(bb), 21 U.S.C. § 352(bb)
  2. Because of that false or misleading claim, FDA says the compounded semaglutide products are misbranded.

    FDCA § 502(a), 21 U.S.C. § 352(a); FDCA § 502(bb), 21 U.S.C. § 352(bb)
  3. FDA says introducing or delivering the misbranded products into interstate commerce is prohibited.

    FDCA § 301(a), 21 U.S.C. § 331(a)
  4. FDA also says receiving misbranded drugs in interstate commerce, or delivering or offering to deliver them, is a violation.

    FDCA § 301(c), 21 U.S.C. § 331(c)

What FDA wants

FDA tells Elite Health Center to take immediate action, including ceasing and desisting from using the cited language, and to send a written response within 15 working days describing steps taken, how recurrence will be prevented, and related documentation.

Who should pay attention

  • telehealth companies selling compounded semaglutide
  • compounding pharmacies and their marketing partners
  • clinics or brands that advertise compounded drugs as FDA-approved

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. New Green Nutrition Inc.

    FDA says New Green Nutrition sold unapproved drugs online, and its Qu Feng Huo Luo Dan contained hidden dexamethasone.

    High risk
  2. Ong Tien USA LLC

    FDA warned Ong Tien USA LLC that its herbal joint products are unapproved drugs and one contained hidden piroxicam and dexamethasone.

    High risk
  3. Bella’s Nutri Shop Inc.

    Bella’s Nutri Shop sells “Tawon Liar” as an unapproved drug with hidden dexamethasone, tapentadol, and meloxicam.

    High risk
  4. RonanRx, Inc. dba RonanRx

    FDA says RonanRx's website and X posts misbrand compounded semaglutide and tirzepatide with false or misleading claims.

    Low